Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7672)
All Articles published online
|
Jul 7, 2015 (publication date) through Dec 20, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kang X, Chen K, Li Y, Li J, D'Amico TA, Chen X. Personalized targeted therapy for esophageal squamous cell carcinoma. World J Gastroenterol 2015; 21(25): 7648-7658 [PMID: 26167067 DOI: 10.3748/wjg.v21.i25.7648] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i25/7648.htm |
| Number | Citing Articles |
| 1 |
Ah-Won Kwak, Goo Yoon, Mee-Hyun Lee, Seung-Sik Cho, Jung-Hyun Shim, Jung-Il Chae. Picropodophyllotoxin, an Epimer of Podophyllotoxin, Causes Apoptosis of Human Esophageal Squamous Cell Carcinoma Cells Through ROS-Mediated JNK/P38 MAPK Pathways. International Journal of Molecular Sciences 2020; 21(13): 4640 doi: 10.3390/ijms21134640
|
| 2 |
Hiroki Ueda, Daisuke Ban, Atsushi Kudo, Takanori Ochiai, Shinji Tanaka, Minoru Tanabe. Refractory Long‐Term Cholangitis After Pancreaticoduodenectomy: A Retrospective Study. World Journal of Surgery 2017; 41(7): 1882 doi: 10.1007/s00268-017-3912-z
|
| 3 |
Tuhina Khan, Nicola Relitti, Margherita Brindisi, Stefania Magnano, Daniela Zisterer, Sandra Gemma, Stefania Butini, Giuseppe Campiani. Autophagy modulators for the treatment of oral and esophageal squamous cell carcinomas. Medicinal Research Reviews 2020; 40(3): 1002 doi: 10.1002/med.21646
|
| 4 |
Bo-Hyun You, Jung-Ho Yoon, Hoin Kang, Eun Kyung Lee, Sang Kil Lee, Jin-Wu Nam. HERES, a lncRNA that regulates canonical and noncanonical Wnt signaling pathways via interaction with EZH2. Proceedings of the National Academy of Sciences 2019; 116(49): 24620 doi: 10.1073/pnas.1912126116
|
| 5 |
Chung S. Yang, Xiaoxin Luke Chen. Research on esophageal cancer: With personal perspectives from studies in China and Kenya. International Journal of Cancer 2021; 149(2): 264 doi: 10.1002/ijc.33421
|
| 6 |
Guiqin Hou, Tengda Niu, Ang Jia, Yingying Zhang, Xunan Chen, Huiyun Wei, Yilin Jia, Yichao Xu, Yan Li, Pengju Wang, Aniruddha Chatterjee. NRG1 promotes tumorigenesis and metastasis and afatinib treatment efficiency is enhanced by NRG1 inhibition in esophageal squamous cell carcinoma. Biochemical Pharmacology 2023; 218: 115920 doi: 10.1016/j.bcp.2023.115920
|
| 7 |
Mingrui Shao, Wenya Li. Transcriptional factor regulation network and competitive endogenous RNA (ceRNA) network determining response of esophageal squamous cell carcinomas to neoadjuvant chemoradiotherapy. PeerJ 2019; 7: e6668 doi: 10.7717/peerj.6668
|
| 8 |
Yi-Xin Zhao, He-Ping Zhao, Meng-Yao Zhao, Yan Yu, Xi Qi, Ji-Han Wang, Jing Lv. Latest insights into the global epidemiological features, screening, early diagnosis and prognosis prediction of esophageal squamous cell carcinoma. World Journal of Gastroenterology 2024; 30(20): 2638-2656 doi: 10.3748/wjg.v30.i20.2638
Abstract(285) |
Core Tip(314) |
Full Article(HTML)(1711)
|
Full Article with Cover (PDF)-4435K(57)
|
Audio-1541K(7)
|
Peer-Review Report-172K(41)
|
Answering Reviewers-289K(34)
|
Supplementary Material-263K(56)
|
Full Article (PDF)-4016K(109)
|
Full Article (XML)-433K(35)
|
Times Cited (2)
|
Total Visits (3657)
|
Open
|
| 9 |
Chengyi Mao, Xiaoxi Zeng, Chao Zhang, Yushang Yang, Xin Xiao, Siyuan Luan, Yonggang Zhang, Yong Yuan. Mechanisms of Pharmaceutical Therapy and Drug Resistance in Esophageal Cancer. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.612451
|
| 10 |
Chorlada Paiboonrungruang, Emily Simpson, Zhaohui Xiong, Caizhi Huang, Jianying Li, Yahui Li, Xiaoxin Chen. Development of targeted therapy of NRF2high esophageal squamous cell carcinoma. Cellular Signalling 2021; 86: 110105 doi: 10.1016/j.cellsig.2021.110105
|
| 11 |
Lehang Lin, De-Chen Lin. Biological Significance of Tumor Heterogeneity in Esophageal Squamous Cell Carcinoma. Cancers 2019; 11(8): 1156 doi: 10.3390/cancers11081156
|
| 12 |
Lei Wei, Bo Wang, Liwen Hu, Yang Xu, Zhongdong Li, Yi Shen, Hairong Huang. MEX3A is upregulated in esophageal squamous cell carcinoma (ESCC) and promotes development and progression of ESCC through targeting CDK6. Aging 2020; 12(21): 21091 doi: 10.18632/aging.103196
|
| 13 |
Ting Yan, Heyang Cui, Yong Zhou, Bin Yang, Pengzhou Kong, Yingchun Zhang, Yiqian Liu, Bin Wang, Yikun Cheng, Jiayi Li, Shixing Guo, Enwei Xu, Huijuan Liu, Caixia Cheng, Ling Zhang, Ling Chen, Xiaofei Zhuang, Yu Qian, Jian Yang, Yanchun Ma, Hongyi Li, Fang Wang, Jing Liu, Xuefeng Liu, Dan Su, Yan Wang, Ruifang Sun, Shiping Guo, Yaoping Li, Xiaolong Cheng, Zhihua Liu, Qimin Zhan, Yongping Cui. Multi-region sequencing unveils novel actionable targets and spatial heterogeneity in esophageal squamous cell carcinoma. Nature Communications 2019; 10(1) doi: 10.1038/s41467-019-09255-1
|
| 14 |
Fei Yang, Shiwang Wen, Yuefeng Zhang, Yanzhao Xu, Huilai Lv, Yonggang Zhu, Mingbo Wang, Peng Su, Chao Huang, Ziqiang Tian. Identifying potential metastasis‐related long non‐coding RNAs, microRNAs, and message RNAs in the esophageal squamous cell carcinoma. Journal of Cellular Biochemistry 2019; 120(8): 13202 doi: 10.1002/jcb.28594
|
| 15 |
Chorlada Paiboonrungruang, Zhaohui Xiong, David Lamson, Yahui Li, Brittany Bowman, Julius Chembo, Caizhi Huang, Jianying Li, Eric W. Livingston, Jon E. Frank, Vivian Chen, Yong Li, Bernard Weissman, Hong Yuan, Kevin P. Williams, M. Ben Major, Xiaoxin Chen. Small molecule screen identifies pyrimethamine as an inhibitor of NRF2-driven esophageal hyperplasia. Redox Biology 2023; 67: 102901 doi: 10.1016/j.redox.2023.102901
|
| 16 |
Inamu Rashid Khan, Hana Q. Sadida, Sheema Hashem, Mayank Singh, Muzafar A. Macha, Ammira S. Al-Shabeeb Akil, Ibraq Khurshid, Ajaz A. Bhat. Therapeutic implications of signaling pathways and tumor microenvironment interactions in esophageal cancer. Biomedicine & Pharmacotherapy 2024; 176: 116873 doi: 10.1016/j.biopha.2024.116873
|
| 17 |
Zhaoming Lu, Yandan Ren, Li Yang, Ang Jia, Yi Hu, Yu Zhao, Wuduo Zhao, Bin Yu, Wen Zhao, Jianying Zhang, Guiqin Hou. Inhibiting autophagy enhances sulforaphane-induced apoptosis via targeting NRF2 in esophageal squamous cell carcinoma. Acta Pharmaceutica Sinica B 2021; 11(5): 1246 doi: 10.1016/j.apsb.2020.12.009
|
| 18 |
Meng-Meng Gu, Ming Li, Dexuan Gao, Lang-Huan Liu, Yue Lang, Si-Ming Yang, Hongling Ou, Bo Huang, Ping-Kun Zhou, Zeng-Fu Shang. The vanillin derivative 6-bromine-5-hydroxy-4-methoxybenzaldehyde induces aberrant mitotic progression and enhances radio-sensitivity accompanying suppression the expression of PLK1 in esophageal squamous cell carcinoma. Toxicology and Applied Pharmacology 2018; 348: 76 doi: 10.1016/j.taap.2018.04.021
|
| 19 |
Chung S. Yang, Xiaoxin Chen, Shuiping Tu. Etiology and Prevention of Esophageal Cancer. Gastrointestinal Tumors 2016; 3(1): 3 doi: 10.1159/000443155
|
| 20 |
Pan Pan, Daniel S. Peiffer, Yi-Wen Huang, Kiyoko Oshima, Gary D. Stoner, Li-Shu Wang. Inhibition of the development of N-nitrosomethylbenzylamine-induced esophageal tumors in rats by strawberries and aspirin, alone and in combination. Journal of Berry Research 2018; 8(2): 137 doi: 10.3233/JBR-170291
|
| 21 |
Dohee Kwon, Ji Yun Yun, Bhumsuk Keam, Young Tae Kim, Yoon Kyung Jeon. Prognostic implications of <i>FGFR1</i> and <i>MYC</i> status in esophageal squamous cell carcinoma. World Journal of Gastroenterology 2016; 22(44): 9803-9812 doi: 10.3748/wjg.v22.i44.9803
|
| 22 |
Yahui Li, Qing Cheng, Zhaohui Xiong, Chorlada Paiboonrungruang, Timothy Adekoya, Yong Li, Xiaoxin Chen. Lymphatic Drainage System and Lymphatic Metastasis of Cancer Cells in the Mouse Esophagus. Digestive Diseases and Sciences 2023; 68(3): 803 doi: 10.1007/s10620-022-07586-6
|
| 23 |
Poojarani Panda, Henu Kumar Verma, Lakkakula V. K. S. Bhaskar. Precision Medicine Revolutionizing Esophageal Cancer Treatment: Surmounting Hurdles and Enhancing Therapeutic Efficacy through Targeted Drug Therapies. Onco 2023; 3(3): 127 doi: 10.3390/onco3030010
|
| 24 |
Yumiao Zhao, Jiaxin Sun, Yin Li, Xiuman Zhou, Wenjie Zhai, Yahong Wu, Guanyu Chen, Shanshan Gou, Xinghua Sui, Wenshan Zhao, Lu Qiu, Yongjie Yao, Yixuan Sun, Chunxia Chen, Yuanming Qi, Yanfeng Gao. Tryptophan 2,3-dioxygenase 2 controls M2 macrophages polarization to promote esophageal squamous cell carcinoma progression via AKT/GSK3β/IL-8 signaling pathway. Acta Pharmaceutica Sinica B 2021; 11(9): 2835 doi: 10.1016/j.apsb.2021.03.009
|
| 25 |
Xueyin Zu, Xiaomeng Xie, Yuanyuan Zhang, Kangdong Liu, Ann M. Bode, Zigang Dong, Dong Joon Kim. Lapachol is a novel ribosomal protein S6 kinase 2 inhibitor that suppresses growth and induces intrinsic apoptosis in esophageal squamous cell carcinoma cells. Phytotherapy Research 2019; 33(9): 2337 doi: 10.1002/ptr.6415
|
| 26 |
Qingjie Min, Yan Wang, Qingnan Wu, Xianfeng Li, Huajing Teng, Jiawen Fan, Yiren Cao, Pingsheng Fan, Qimin Zhan. Genomic and epigenomic evolution of acquired resistance to combination therapy in esophageal squamous cell carcinoma. JCI Insight 2021; 6(17) doi: 10.1172/jci.insight.150203
|
| 27 |
Xing He, Hezhong Yan, Jie Hu, Xiaowei Duan, Mingjin Zhang, Haiqing Li, Jiaoxue Wang, Qian Gao, Senyuan Yu, Xilu Hou, Guobin Liao, Shicun Guo, Jin Li, Yurong Ge, Xiaolan Chen, Wenchao Wang, Jun Tang. HDS screening with patient-derived primary cells guided individualized therapy for esophageal squamous cell carcinoma–in vivo and vitro. Frontiers in Medicine 2023; 10 doi: 10.3389/fmed.2023.1212851
|
| 28 |
Yong Li, Yahui Li, Xiaoxin Chen. Notch Signaling in Embryology and Cancer. Advances in Experimental Medicine and Biology 2021; 1287: 59 doi: 10.1007/978-3-030-55031-8_5
|
| 29 |
Nuo Li, Yang Yu, Baoming Wang. Downregulation of AAA-domain-containing protein 2 restrains cancer stem cell properties in esophageal squamous cell carcinoma via blockade of the Hedgehog signaling pathway. American Journal of Physiology-Cell Physiology 2020; 319(1): C93 doi: 10.1152/ajpcell.00133.2019
|
| 30 |
Qi Wang, Sheng Zhong, Hua Wu, Qingquan Wu. In vitro anti-cancer effect of marmesin by suppression of PI3K/Akt pathway in esophagus cancer cells. Esophagus 2022; 19(1): 163 doi: 10.1007/s10388-021-00872-8
|
| 31 |
Yongjing Liu, Zhaohui Xiong, Andrea Beasley, Thomas D'Amico, Xiaoxin Luke Chen. Personalized and targeted therapy of esophageal squamous cell carcinoma: an update. Annals of the New York Academy of Sciences 2016; 1381(1): 66 doi: 10.1111/nyas.13144
|
| 32 |
Rui Xie, Shang-Nong Wu, Cheng-Cheng Gao, Xiao-Zhong Yang, Hong-Gang Wang, Jia-Ling Zhang, Wei Yan, Tian-Heng Ma. MicroRNA-30d inhibits the migration and invasion of human esophageal squamous cell carcinoma cells via the post-transcriptional regulation of enhancer of zeste homolog 2. Oncology Reports 2017; 37(3): 1682 doi: 10.3892/or.2017.5405
|
| 33 |
Abolfazl Rad, Saeed Esmaeili Dizghandi, Mohammad Reza Abbaszadegan, Negin Taghechian, Maryam Najafi, Mohammad Mahdi Forghanifard. SOX1 is correlated to stemness state regulator SALL4 through progression and invasiveness of esophageal squamous cell carcinoma. Gene 2016; 594(2): 171 doi: 10.1016/j.gene.2016.08.045
|
| 34 |
Haidi Huang, Yu Jiang, Jiangying Liu, Dan Luo, Jianghong Yuan, Rongzi Mu, Xiang Yu, Donglei Sun, Jihong Lin, Qiyue Chen, Xinjing Li, Ming Jiang, Jianming Xu, Bo Chu, Chengqian Yin, Lei Zhang, Youqiong Ye, Bo Cao, Qiong Wang, Yongchun Zhang. Jag1/2 maintain esophageal homeostasis and suppress foregut tumorigenesis by restricting the basal progenitor cell pool. Nature Communications 2024; 15(1) doi: 10.1038/s41467-024-48347-5
|
| 35 |
Jialin Li, Ming Li, Feng Gao, Xiaojun Ge. Serum microRNA-15a level acts as a potential diagnostic and prognostic biomarker for human esophageal squamous cell carcinoma. Cancer Biomarkers 2017; 18(1): 11 doi: 10.3233/CBM-160667
|
| 36 |
Ya‐Tian Liu, Dan Zong, Xue‐Song Jiang, Li Yin, Li‐Jun Wang, Ting‐Ting Wang, Jun Zhu, Xia He. miR‐32 promotes esophageal squamous cell carcinoma metastasis by targeting CXXC5. Journal of Cellular Biochemistry 2019; 120(4): 6250 doi: 10.1002/jcb.27912
|
| 37 |
Heng Xu, Haixia Cao, Junying Zhang, Changwen Jing, Zhuo Wang, Jianzhong Wu, Mengjie Du, Xuyun Xu, Rong Ma. Serum VEGF levels as a predictor of recurrence in patients with advanced‑stage esophageal squamous cell carcinoma following curative esophagectomy followed by chemotherapy or concurrent radiotherapy. Molecular and Clinical Oncology 2023; 19(5) doi: 10.3892/mco.2023.2682
|